Valentin Vlassov
Overview
Explore the profile of Valentin Vlassov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
328
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oshchepkova A, Chernikov I, Miroshnichenko S, Patutina O, Markov O, Savin I, et al.
Front Bioeng Biotechnol
. 2024 Nov;
12:1437817.
PMID: 39493304
Introduction: Small membrane particles called extracellular vesicles (EVs) transport biologically active cargo between cells, providing intercellular communication. The clinical application of EVs is limited due to the lack of scalable...
2.
Chiglintseva D, Clarke D, Senkova A, Heyman T, Miroshnichenko S, Shan F, et al.
Biomaterials
. 2024 May;
309:122604.
PMID: 38733658
Rationally-engineered functional biomaterials offer the opportunity to interface with complex biology in a predictive, precise, yet dynamic way to reprogram their behaviour and correct shortcomings. Success here may lead to...
3.
Matveeva A, Vinogradov D, Zhuravlev E, Semenov D, Vlassov V, Stepanov G
Int J Mol Sci
. 2023 Dec;
24(24).
PMID: 38139448
The gene encodes a long non-coding RNA (lncRNA) and intron-located small nucleolar RNAs (snoRNAs). Its structure, splice variants, and diverse functions in mammalian cells have been thoroughly investigated. However, there...
4.
Oshchepkova A, Zenkova M, Vlassov V
Int J Mol Sci
. 2023 Apr;
24(8).
PMID: 37108446
Extracellular vesicles (EVs) are membrane vesicles released into the extracellular milieu by cells of various origins. They contain different biological cargoes, protecting them from degradation by environmental factors. There is...
5.
Gaponova S, Patutina O, Senkova A, Burakova E, Savin I, Markov A, et al.
Cancers (Basel)
. 2022 Sep;
14(18).
PMID: 36139555
Rational combinations of sequence-specific inhibitors of pro-oncogenic miRNAs can efficiently interfere with specific tumor survival pathways, offering great promise for targeted therapy of oncological diseases. Herein, we uncovered the potential...
6.
Nilsen T, Altman A, Stark B, Feinstein S, Koski R, Mickiewicz C, et al.
RNA
. 2022 Sep;
28(11):1393-1429.
PMID: 36113877
No abstract available.
7.
Patutina O, Chiglintseva D, Amirloo B, Clarke D, Gaponova S, Vlassov V, et al.
Int J Mol Sci
. 2022 Jun;
23(12).
PMID: 35743015
The selective degradation of disease-associated microRNA is promising for the development of new therapeutic approaches. In this study, we engineered a series of bulge-loop-forming oligonucleotides conjugated with catalytic peptide [(LeuArg)Gly]...
8.
Oshchepkova A, Markov O, Evtushenko E, Chernonosov A, Kiseleva E, Morozova K, et al.
Pharmaceutics
. 2021 Nov;
13(11).
PMID: 34834326
The main advantage of extracellular vesicles (EVs) as a drug carrier system is their low immunogenicity and internalization by mammalian cells. EVs are often considered a cell-specific delivery system, but...
9.
Chechushkov A, Kozlova Y, Baykov I, Morozova V, Kravchuk B, Ushakova T, et al.
Viruses
. 2021 Jul;
13(7).
PMID: 34206836
Bacteriophages are promising antibacterial agents. Although they have been recognized as bacterial viruses and are considered to be non-interacting with eukaryotic cells, there is growing evidence that phages may have...
10.
Kozhieva M, Naumova N, Alikina T, Boyko A, Vlassov V, Kabilov M
Life (Basel)
. 2021 Jan;
11(1).
PMID: 33466726
The multiple sclerosis (MS) incidence rate has been increasing in Russia, but the information about the gut bacteriobiome in the MS-afflicted patients is scarce. Using the Illumina MiSeq sequencing of...